Age, new comorbidities, inflammation, cognitive reserve, and changes in anxiety levels alter drug effects and recovery.

The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...

Wearable health technology is rapidly evolving from passive tracking to active physiological modulation. What began with step ...

Recent research shows that GLP-1s may help reduce the need for emergency care in those with chronic migraine. This research ...

A preliminary study conducted by researchers in Brazil and the United States suggests that GLP-1 medications used for weight loss, such as Ozempic and Wegovy, may help reduce emergency room visits and ...

The most powerful biohacks might be free, but that hasn’t stopped health-conscious high rollers from shelling out serious ...

CRT is one of the world’s leading educational forums for interventional cardiovascular medicine, with Top Abstract podium selections representing the highest-scoring submissions based on scientific ...

If you opened it and then did that little stealth maneuver — phone tucked closer to your chest, eyes darting, maybe even a quick dash to the bathroom because the word masturbation still has the power ...

Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule modulatorsExpanded collaboration into Ono’s other priority ...

A cup of tea really could make you feel better, according to a raft of research which shows its benefits for a whole host of ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...

Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candidates in ...